IMPLICIT BIOSCIENCE

We are a private company, with a noble investment proposition, welcoming support from philanthropists, private investors and government sources... IC14 regulates pathogenic inflammatory responses to infection and injury, and has great potential across a variety of disease areas. Right now, we are focused on testing its efficacy in the fight against motor neurone disease (MND) or amyotrophic lateral sclerosis (ALS); cardioimmunology; and all-cause acute respiratory distress syndrome (ARDS) .

Primary location: Seattle United States